Comparison of the Evaluation of CAD by CT AngioScan and Coronary Angiogram (CTAS-MCAS)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The use of CT Coronary Angioscan (CT-AS) is gaining popularity, but its exact value as evaluation of CAD requires confirmation. We intend to compare the results of CT-AS and convention coronary angiogram results in patients who are scheduled for an ascending aorta aneurysm reparation surgery. These examens are standard of care before this surgery, so there is no additional danger or disadvantage for the patient. We hope to confirm that CT-AS is a reliable screening test for CAD in patient undergoing heart surgery for other reason than CAD.
| Condition |
|---|
|
Coronary Artery Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Comparison of the Evaluation of CAD by CT AngioScan and Coronary Angiogram in Patient as Part of Preoperative Evaluation in Ascending Aorta Replacement Surgery Patients. |
- Presence of CAD [ Time Frame: less than 6 monthes between two tests ] [ Designated as safety issue: No ]The CAD seen on CT-AS as compared to the results of the gold-standard test of coronary angiogram.
| Estimated Enrollment: | 100 |
| Study Start Date: | January 2013 |
| Estimated Study Completion Date: | February 2015 |
| Estimated Primary Completion Date: | February 2015 (Final data collection date for primary outcome measure) |
Eligibility| Ages Eligible for Study: | 18 Years to 89 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients with ascending aorta aneurysm undergoing preoperative evaluation of CAD by CT-Angioscan and Coronary angiogramm before surgical reparation.
Inclusion Criteria:
- Ascending aorta aneurysm waiting for surgical correction
- Willing to participate
- Needing a Coronary angiogram and a CT-AS for medical reasons
Exclusion Criteria:
- Refuse to participate
- Allergy to contrast material
- Incomplete results or having one of the test done in another hospital
- Arrythmia
- More than 6 months between the two exams
Contacts and Locations| Canada, Quebec | |
| CHUS Fleurimont | Recruiting |
| Sherbrooke, Quebec, Canada, J1H 5N4 | |
| Contact: Paul Farand, M.Sc 819-346-1110 paul.farand@sherbrooke.ca | |
| Principal Investigator: Gérald Gahide, MD | |
| Sub-Investigator: Paul Farand, MD, MSc | |
| Sub-Investigator: Tamas Z Fulop, MD | |
| Sub-Investigator: Francis Rivest, MD | |
| Principal Investigator: | Gerald Gahide, MD PHD | Universite de Sherbrooke |
More Information
No publications provided
| Responsible Party: | Universitaire de Sherbrooke |
| ClinicalTrials.gov Identifier: | NCT01779986 History of Changes |
| Other Study ID Numbers: | CTAS-MCAS UdeS 12-073 |
| Study First Received: | January 28, 2013 |
| Last Updated: | January 29, 2013 |
| Health Authority: | Canada: Ethics Review Committee |
Additional relevant MeSH terms:
|
Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases |
Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases |
ClinicalTrials.gov processed this record on May 22, 2013